Myelofibrosis

Latest News

red blood cells erythrocytes close-up. Scientific medical background
Fedratinib Shows Efficacy in Previously Treated Myelofibrosis, Some Patients With Ruxolitinib Failure

January 29th 2025

Data indicates fedratinib’s role as an effective second-line treatment in patients with myelofibrosis who have been previously treated with a JAK inhibitor, such as ruxolitinib, though more research is necessary.

Blood clot illustration, Thrombosis is a dangerouse disease which can lead to a stroke or heart attack
Cardiovascular Risk Factors Increase Thrombosis, Mortality in Patients With Myelofibrosis, Other MPNs

January 27th 2025

Microscopic view of red blood cells (erythrocytes) for a scientific or medical theme
Patients With Myelofibrosis Face Long-Term Treatment and Hospitalization Despite Improvements in Therapy

January 23rd 2025

Myelofibrosis Treatment Options: A Guide for Pharmacists
Myelofibrosis Treatment Options: A Guide for Pharmacists

January 2nd 2025

Hemoglobin deficiency and red blood cell anemia | Image Credit: © loran4a - stock.adobe.com
Gecacitinib Demonstrates Safety, Efficacy Over Hydroxyurea in Patients With Myelofibrosis and Anemia

December 25th 2024

<123